Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Aug;103(4):1992–1996. doi: 10.1111/j.1476-5381.1991.tb12365.x

In vitro vascular effects of cicletanine in pregnancy-induced hypertension.

A B Ebeigbe 1, M Cabanie 1
PMCID: PMC1908211  PMID: 1912987

Abstract

1. The vascular effects of cicletanine have been studied in vitro on ring preparations of inferior epigastric arteries from normotensive human females and human females with pregnancy-induced hypertension (preeclampsia). 2. Cicletanine (10(-7)-10(-3) M) elicited concentration-dependent relaxation of vessels precontracted with 10(-7) M noradrenaline (NA) or 60 mM K+ but was more potent in the former. Relaxation was significantly greater in rings from preeclamptic patients and was uninfluenced by endothelium removal. 3. The intracellular Ca-dependent contractile responses to 10(-5) M NA in Ca-free medium as well as the subsequent extracellular Ca-dependent contractions (on restoration of external Ca) were significantly attenuated dose-dependently by cicletanine (10(-5) M, 3 x 10(-4) M) in arterial rings from both normotensive and preeclamptic patients. Cicletanine also relaxed rings precontracted by 25 mM K+ but was ineffective against 80 mM K(+)-induced contractions. 4. The inhibition of intracellular Ca-dependent contractions was significantly greater in rings from preeclamptic than from normotensive patients whereas extracellular Ca-dependent contractions were comparably inhibited in both groups. Nifedipine, on the other hand, had little effect on the intracellular Ca-dependent contractions but significantly depressed extracellular Ca-dependent contractions. 5. Cicletanine-induced relaxation was uninfluenced by pretreatment with propranolol, ouabain, tetraethylammonium, procaine, indomethacin, cimetidine or tetrodotoxin but was antagonized by glibenclamide. 6. The results show that cicletanine inhibits contractile responses of human isolated inferior epigastric arteries by a mechanism unrelated to endothelial factors but associated with inhibition of calcium metabolism. An action of cicletanine on glibenclamide-sensitive K+ channels is also suggested. Cicletanine-induced inhibition was significantly greater in arteries from preclamptic patients.

Full text

PDF
1992

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aalkjaer C., Danielsen H., Johannesen P., Pedersen E. B., Rasmussen A., Mulvany M. J. Abnormal vascular function and morphology in pre-eclampsia: a study of isolated resistance vessels. Clin Sci (Lond) 1985 Oct;69(4):477–482. doi: 10.1042/cs0690477. [DOI] [PubMed] [Google Scholar]
  2. Aoki K., Kawaguchi Y., Sato K., Kondo S., Yamamoto M. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1982;4 (Suppl 3):S298–S302. [PubMed] [Google Scholar]
  3. Auguet M., Guillon J. M., Delaflotte S., Le Hegarat M., Pirotzky E., Clostre F., Braquet P. In vivo and in vitro effects of cicletanine in spontaneously hypertensive rats. Drugs Exp Clin Res. 1988;14(2-3):89–95. [PubMed] [Google Scholar]
  4. Bohr D. F. Vascular smooth muscle updated. Circ Res. 1973 Jun;32(6):665–672. doi: 10.1161/01.res.32.6.665. [DOI] [PubMed] [Google Scholar]
  5. Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979 Jul;59(3):606–718. doi: 10.1152/physrev.1979.59.3.606. [DOI] [PubMed] [Google Scholar]
  6. Ebeigbe A. B., Cabanie M., Godfraind T. Effects of cicletanine on histamine-induced contractions of isolated rabbit mesenteric arteries. Fundam Clin Pharmacol. 1989;3(3):223–235. doi: 10.1111/j.1472-8206.1989.tb00453.x. [DOI] [PubMed] [Google Scholar]
  7. Ebeigbe A. B. Calcium pools for noradrenaline and potassium-induced contractions of rat portal vein. Can J Physiol Pharmacol. 1982 Sep;60(9):1225–1227. doi: 10.1139/y82-177. [DOI] [PubMed] [Google Scholar]
  8. Ebeigbe A. B., Ezimokhai M., Aloamaka C. P. Responses of arterial smooth muscle from normotensive and pre-eclamptic subjects to the calcium channel agonist, Bay K 8644. Res Exp Med (Berl) 1987;187(6):461–468. doi: 10.1007/BF01852184. [DOI] [PubMed] [Google Scholar]
  9. Ebeigbe A. B., Ezimokhai M. Vascular smooth muscle responses in pregnancy-induced hypertension. Trends Pharmacol Sci. 1988 Dec;9(12):455–457. doi: 10.1016/0165-6147(88)90138-1. [DOI] [PubMed] [Google Scholar]
  10. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  11. Malherbe E., Le Hegarat M., Clostre F., Braquet P. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models. Drugs Exp Clin Res. 1988;14(2-3):83–88. [PubMed] [Google Scholar]
  12. Schoeffter P., Ghysel-Burton J., Cabanie M., Godfraind T. Competitive and stereoselective histamine H1 antagonistic effect of cicletanide in guinea-pig isolated ileum. Eur J Pharmacol. 1987 Apr 14;136(2):235–237. doi: 10.1016/0014-2999(87)90716-3. [DOI] [PubMed] [Google Scholar]
  13. Schoeffter P., Godfraind T. Antihistaminic properties of cicletanine in human isolated coronary arteries. Drugs Exp Clin Res. 1988;14(2-3):159–165. [PubMed] [Google Scholar]
  14. Schoeffter P., Godfraind T. Histamine receptors in the smooth muscle of human internal mammary artery and saphenous vein. Pharmacol Toxicol. 1989 Jan;64(1):64–71. doi: 10.1111/j.1600-0773.1989.tb00603.x. [DOI] [PubMed] [Google Scholar]
  15. Webb R. C., Bohr D. F. Recent advances in the pathogenesis of hypertension: consideration of structural, functional, and metabolic vascular abnormalities resulting in elevated arterial resistance. Am Heart J. 1981 Aug;102(2):251–264. doi: 10.1016/s0002-8703(81)80016-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES